Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. (Q39470265)
Jump to navigation
Jump to search
scientific article published on 22 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. |
scientific article published on 22 August 2011 |
Statements
Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts (English)
Celine Leteur
Tarig Bashir
Bruno Schoentjes
Janine Arts
Michel Janicot
Jean Bourhis
22 August 2011